Literature DB >> 21947739

Verification of surface contamination of Japanese cyclophosphamide vials and an example of exposure by handling.

Koji Hama1, Koichi Fukushima, Masaki Hirabatake, Tohru Hashida, Kazusaburo Kataoka.   

Abstract

PURPOSE: Cyclophosphamide (CP) contamination has been detected in Japanese hospitals. In other countries, the surface contamination of CP vials has been reported; however, the manufacturing process of Japanese CP vials is unknown, so the conditions are not necessarily the same as in other countries. This study aimed to establish whether vial surface contamination also occurs in Japan.
METHOD: Contamination of vial surfaces was examined with a wipe test. Urine samples were taken from a pharmacist, engaged solely in dispensing work, for 29 h. It was also investigated whether CP vials were dispensed during the urine sampling period. In addition, vial surfaces, purposely coated with CP and then washed, were examined using wipe tests. RESULT: CP was detected at 30-60% in vials, which was 11-62 ng (0.10-0.54 ng/cm(2)). One of the urine samples was contaminated (CP 13.5 ng); this was taken on Day 2 (11:35 AM). CP was not detected among the washed vials. DISCUSSION: This study shows that the surface of Japanese CP vials was contaminated and that it was probable that healthcare workers were exposed to CP. CP absorption by the pharmacist was probably due to dermal uptake while dispensing. Washing the vial is considered effective to avoid CP exposure. Manufacturers should be more proactive to prevent contamination and healthcare workers should comply with exposure prevention rules. Cytotoxic drugs should be included in institution monitoring lists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21947739     DOI: 10.1177/1078155211419543

Source DB:  PubMed          Journal:  J Oncol Pharm Pract        ISSN: 1078-1552            Impact factor:   1.809


  7 in total

1.  Hazardous drug residue on exterior vial surfaces: evaluation of a commercial manufacturing process.

Authors:  Luci A Power; Paul J M Sessink; Kathy Gesy; Flay Charbonneau
Journal:  Hosp Pharm       Date:  2014-04

Review 2.  Applicability of the comet assay in evaluation of DNA damage in healthcare providers' working with antineoplastic drugs: a systematic review and meta-analysis.

Authors:  Mohammad Javad Zare Sakhvidi; Mohammad Hajaghazadeh; Mehrdad Mostaghaci; Amir Houshang Mehrparvar; Fariba Zare Sakhvidi; Elham Naghshineh
Journal:  Int J Occup Environ Health       Date:  2016-04-25

Review 3. 

Authors:  Céline Poupeau; Christel Roland; Jean-François Bussières
Journal:  Can J Hosp Pharm       Date:  2016-10-31

4.  Establishment and validation of analytical methods for 15 hazardous drugs by UPLC-Q/Orbitrap-HRMS.

Authors:  Bo Yu; Yang Wang; Zhou Geng; Yuchen Qu; Jie Pan; Qing Zhai
Journal:  Ann Transl Med       Date:  2022-06

5.  Performance evaluation of the compounding robot, APOTECAchemo, for injectable anticancer drugs in a Japanese hospital.

Authors:  Takuya Iwamoto; Takuya Morikawa; Miki Hioki; Hirofumi Sudo; Demis Paolucci; Masahiro Okuda
Journal:  J Pharm Health Care Sci       Date:  2017-04-24

6.  Environmental assessment of cytotoxic drugs in the Oncology Center of Cyprus.

Authors:  Elpidoforos S Soteriades; Sofia C Economidou; Artemis Tsivitanidou; Petros Polyviou; Amanda Lorimer; Nikos Katodritis; Stavroula Theophanous-Kitiri
Journal:  PLoS One       Date:  2020-03-05       Impact factor: 3.240

7.  Occupational risks evaluation in a centralized antineoplastic agent preparation unit.

Authors:  Quentin Dubray; Taibou Diallo; Richard Loeuillet; Emilie Andre; Anne-Sophie Fauqueur; Sandrine Poil; Nathalie Thromas; Philippe-Henri Secretan; Salvatore Cisternino; Joël Schlatter
Journal:  SAGE Open Med       Date:  2019-07-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.